The medical landscape is seeing a development with the arrival of GLP-1 transdermal systems . These innovative formulations offer a possible alternative to delivering glucagon-like peptide-1 medication for individuals managing type 2 diabetes . Instead of needles, a simple patch affixed to the skin could provide a steady quantity of the substance,